Apogenix ǀ Immuno-oncology therapeutics for the treatment of cancer and other malignant diseases

http://apogenix.de/unternehmensfuehrung/beirat/

Apogenix develops innovative protein therapeutics for the treatment of cancer and other malignant diseases. Our lead drug candidate APG101 has demonstrated a statistically significant efficacy in a controlled phase II trial in recurrent glioblastoma.